Updated 8:56 a.m. ET, November 18, 2020
- A final analysis of the Phase 3 trial of Pfizer's coronavirus vaccine shows it was 95% effective, the company announced today. Yesterday, Moderna announced its vaccine is 94.5% effective.
- Experts are encouraged by early Covid-19 vaccine findings, but warn the world still faces challenging months ahead.
- The US has recorded more than 100,000 daily infections for two weeks straight, prompting more states to announce new restrictions to slow the spread.
- France became the first country in Europe to top 2 million confirmed cases of coronavirus, according to data from Johns Hopkins University.